Patent Expiry
CPRX: FIRDAPSE: recorded patent 10626088 expiry
February 25, 2037 · AMIFAMPRIDINE PHOSPHATE. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- February 25, 2037
- Company
- CATALYST PHARMACEUTICALS, INC. (CPRX)
- Drug
- AMIFAMPRIDINE PHOSPHATE
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
FIRDAPSE: recorded patent 10626088 expiry
Orange Book application NDA208078, product 001, listed patent 10626088 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source